Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Hetero Labs Limited (Unit V)
EIR
•Hetero Labs Limited (Unit V)•December 16, 2016

Hetero Labs Limited (Unit V) – FDA EIR, Dec 16, 2016

Record Details

The U.S. Food and Drug Administration (FDA) conducted a comprehensive Good Manufacturing Practice (GMP) inspection of Hetero Labs Limited Unit V in Jadcherla Mandal, India, from December 7 to December 16, 2016. This pre-announced inspection, guided by drug manufacturing inspection policies, focused on the facility's quality, facilities and equipment, laboratory, and production systems for finished drug products intended for the U.S. market, operating under the regulatory framework of the FD&C Act and 21 CFR Part 211. Eight significant observations were documented on an FDA Form 483. Major findings included the quality control unit not fully adhering to its procedures, evidenced by the documented destruction and alteration of commercial batch manufacturing records immediately prior to the inspection, and controlled documents found discarded in scrap and trash areas. Other critical issues involved incomplete batch production and control records, inadequate investigation and record-keeping for drug complaints, and poorly cleaned and maintained equipment and utensils displaying residues and damage on product contact surfaces. Furthermore, the company failed to document deviations from production time limits, lacked established and documented accuracy for test methods, and showed insufficient controls over computer systems, including numerous unexplained user aborts in the QC laboratory. Hetero Labs management acknowledged the inspectional concerns and committed to submitting a comprehensive written response to the FDA within fifteen business days to address the identified deficiencies.

Company
Hetero Labs Limited (Unit V)
Inspection date
December 16, 2016
Product type
Drugs
People
  • Massoud Motamed (Biologist at CBER)
  • Latorie S. Jones (Consumer Safety Officer at Commissioned Corps of the U.S. Public Health Service)
  • Hassan Ramappa Kamalamma Mahesh (company_representative)
  • Srinivas Rao (company_representative)
  • Pabbati Reddy Bhaskar Reddy (recipient)
View Company Profile

ID · d5648335-9764-4837-91ee-29f8eedcdcbd

Other documents for Hetero Labs Limited (Unit V)
  • 483 - 2026-08-07August 7, 2026
  • EIR - 2022-08-12August 12, 2022
  • 483 - 2022-08-12August 12, 2022
  • 483 - 2016-12-16December 16, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hetero Labs Limited (Unit V)
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.